Figure 2.

The cost-effectiveness acceptability curve for in vitro fertilization (IVF) with preimplantation genetic testing for aneuploidy (PGT-A) compared with IVF without PGT-A for donor oocyte cycles. The X-axis denotes the different thresholds for willingness to pay in US dollars; the Y-axis denotes the percent iterations of the simulation that were cost effective; Blue square denotes the percent of iterations for IVF with PGT-A that were cost effective; Red triangle denotes the percent of iterations for IVF without PGT-A that were cost effective.